Cite
HARVARD Citation
Diab, A. et al. (n.d.). 420 Progression-free survival and biomarker correlates of response with BEMPEG plus NIVO in previously untreated patients with metastatic melanoma: results from the PIVOT-02 study. Journal for immunotherapy of cancer. p. A256. [Online].